Skip to Main content Skip to Navigation
Journal articles

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

Complete list of metadata

https://hal.univ-brest.fr/hal-02049783
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Tuesday, February 26, 2019 - 4:10:29 PM
Last modification on : Wednesday, October 27, 2021 - 11:18:59 AM

Identifiers

  • HAL Id : hal-02049783, version 1
`

Citation

Pieternella Lugtenburg, Irit Avivi, Henriette Berenschot, Osman Ilhan, Jean Pierre Marolleau, et al.. Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study. Haematologica, Ferrata Storti Foundation, 2017, 102 (11), pp.1913-1922. ⟨hal-02049783⟩

Share

Metrics

Record views

67